1	Un	Un		C0205447_1	calificador_1	0-2	225_QUEST_clinical_caseMIR	SENT1	-	-
2	paciente	paciente	NCCS000	C0030705	persona	3-11	225_QUEST_clinical_caseMIR	SENT1	-	-
3	con	con	SPS00	C0332287	atributo	12-15	225_QUEST_clinical_caseMIR	SENT1	-	-
4	una	una		C0205447_1	calificador_1	16-19	225_QUEST_clinical_caseMIR	SENT1	-	-
5	historia	historia	NCFS000	-	-	20-28	225_QUEST_clinical_caseMIR	SENT1	-	-
6	de	de	SPS00	C0332285	atributo	29-31	225_QUEST_clinical_caseMIR	SENT1	-	-
7	consumo	consumo	NCMS000	C0560219_1	hallazgo_1	32-39	225_QUEST_clinical_caseMIR	SENT1	-	-
8	excesivo	excesivo	NC00SC0	C0560219_2	hallazgo_2	40-48	225_QUEST_clinical_caseMIR	SENT1	-	-
9	de	de	SPS00	C0560219_3	hallazgo_3	49-51	225_QUEST_clinical_caseMIR	SENT1	-	-
10	alcohol	alcohol	NCMS000	C0560219_4	hallazgo_4	52-59	225_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
11	ha	haber	VAIP3S0	-	-	60-62	225_QUEST_clinical_caseMIR	SENT1	-	-
12	sido	ser	VSP00SM	-	-	63-67	225_QUEST_clinical_caseMIR	SENT1	-	-
13	diagnosticado	diagnosticar	VMP00SM	-	-	68-81	225_QUEST_clinical_caseMIR	SENT1	-	-
14	de	de	SPS00	C0332285	atributo	82-84	225_QUEST_clinical_caseMIR	SENT1	-	-
15	tuberculosis	tuberculosis	NCFN000	C0041327_1	trastorno_1	85-97	225_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
16	pulmonar	pulmonar	NC00SC0	C0041327_2	trastorno_2	98-106	225_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
17	por	por	SPS00	C0678226	atributo	107-110	225_QUEST_clinical_caseMIR	SENT1	-	-
18	un	un		C0205447_1	calificador_1	111-113	225_QUEST_clinical_caseMIR	SENT1	-	-
19	cuadro	cuadro	NCMS000	-	-	114-120	225_QUEST_clinical_caseMIR	SENT1	-	-
20	de	de	SPS00	C0332285	atributo	121-123	225_QUEST_clinical_caseMIR	SENT1	-	-
21	tos	tos	NCFS000	C0010200_1	entidad_observable#hallazgo_1	124-127	225_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
22	,	,	Fc	-	-	127-128	225_QUEST_clinical_caseMIR	SENT1	-	-
23	fiebre	fiebre	NCFS000	C0015967	hallazgo	129-135	225_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
24	,	,	Fc	-	-	135-136	225_QUEST_clinical_caseMIR	SENT1	-	-
25	expectoración	expectoración	NCFS000	C0232515#C0038056	función#sustancia	137-150	225_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
26	,	,	Fc	-	-	150-151	225_QUEST_clinical_caseMIR	SENT1	-	-
27	aislando	aislar	VMG0000	-	-	152-160	225_QUEST_clinical_caseMIR	SENT1	-	-
28	se	se	PP3CN000	-	-	160-162	225_QUEST_clinical_caseMIR	SENT1	-	-
29	en	en	SPS00	C1720294#C0332285	calificador#atributo	163-165	225_QUEST_clinical_caseMIR	SENT1	-	-
30	el	el	DA0MS0	-	-	166-168	225_QUEST_clinical_caseMIR	SENT1	-	-
31	cultivo	cultivo	NCMS000	-	-	169-176	225_QUEST_clinical_caseMIR	SENT1	-	-
32	de	de	SPS00	C0332285	atributo	177-179	225_QUEST_clinical_caseMIR	SENT1	-	-
33	esputo	esputo	NCMS000	C0038056	sustancia	180-186	225_QUEST_clinical_caseMIR	SENT1	-	-
34	Mycobacterium	mycobacterium	NC00SC0	C0026926_1	organismo_1	187-200	225_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
35	tuberculosis	tuberculosis	NCFN000	C0026926_2	organismo_2	201-213	225_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
36	.	.	Fp	-	-	213-214	225_QUEST_clinical_caseMIR	SENT1	-	-

1	El	el	DA0MS0	-	-	215-217	225_QUEST_clinical_caseMIR	SENT2	-	-
2	paciente	paciente	NCCS000	C0030705	persona	218-226	225_QUEST_clinical_caseMIR	SENT2	-	-
3	ha	haber	VAIP3S0	-	-	227-229	225_QUEST_clinical_caseMIR	SENT2	-	-
4	iniciado	iniciar	VMP00SM	-	-	230-238	225_QUEST_clinical_caseMIR	SENT2	-	-
5	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	239-250	225_QUEST_clinical_caseMIR	SENT2	-	-
6	con	con	SPS00	C0332287	atributo	251-254	225_QUEST_clinical_caseMIR	SENT2	-	-
7	isoniacida	isoniacida	NC00SC0	C0022209	producto	255-265	225_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
8	,	,	Fc	-	-	265-266	225_QUEST_clinical_caseMIR	SENT2	-	-
9	rifampicina	rifampicina	NCFS000	C0035608	sustancia	267-278	225_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
10	,	,	Fc	-	-	278-279	225_QUEST_clinical_caseMIR	SENT2	-	-
11	etambutol	etambutol	NC00SC0	C0014964	sustancia	280-289	225_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
12	y	y	CC	C1706368	calificador	290-291	225_QUEST_clinical_caseMIR	SENT2	-	-
13	pirazinamida	pirazinamida	NC00SC0	C0034239	sustancia	292-304	225_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
14	,	,	Fc	-	-	304-305	225_QUEST_clinical_caseMIR	SENT2	-	-
15	con	con	SPS00	C0332287	atributo	306-309	225_QUEST_clinical_caseMIR	SENT2	-	-
16	adecuada	adecuar	VMP00SF	-	-	310-318	225_QUEST_clinical_caseMIR	SENT2	-	-
17	tolerancia	tolerancia	NCFS000	C0231197	entidad_observable	319-329	225_QUEST_clinical_caseMIR	SENT2	-	-
18	.	.	Fp	-	-	329-330	225_QUEST_clinical_caseMIR	SENT2	-	-

1	A	a	SPS00	-	-	331-332	225_QUEST_clinical_caseMIR	SENT3	-	-
2	los	el	DA0MP0	-	-	333-336	225_QUEST_clinical_caseMIR	SENT3	-	-
3	20	20	Z	-	-	337-339	225_QUEST_clinical_caseMIR	SENT3	-	-
4	días	d	NCMP000	-	-	340-344	225_QUEST_clinical_caseMIR	SENT3	-	-
5	del	del	SP+DA	-	-	345-348	225_QUEST_clinical_caseMIR	SENT3	-	-
6	inicio	inicio	NCMS000	C0332162	atributo	349-355	225_QUEST_clinical_caseMIR	SENT3	-	-
7	del	del	SP+DA	-	-	356-359	225_QUEST_clinical_caseMIR	SENT3	-	-
8	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	360-371	225_QUEST_clinical_caseMIR	SENT3	-	-
9	se	se	P00CN000	-	-	372-374	225_QUEST_clinical_caseMIR	SENT3	-	-
10	recibe	recibir	VMIP3S0	-	-	375-381	225_QUEST_clinical_caseMIR	SENT3	-	-
11	un	un		C0205447_1	calificador_1	382-384	225_QUEST_clinical_caseMIR	SENT3	-	-
12	informe	informe	NCMS000	C0684224	elemento_de_registro	385-392	225_QUEST_clinical_caseMIR	SENT3	-	-
13	de	de	SPS00	C0332285	atributo	393-395	225_QUEST_clinical_caseMIR	SENT3	-	-
14	resistencia	resistencia	NCFS000	C0518031	entidad_observable	396-407	225_QUEST_clinical_caseMIR	SENT3	-	-
15	a	a	SPS00	-	-	408-409	225_QUEST_clinical_caseMIR	SENT3	-	-
16	rifampicina	rifampicina	NCFS000	C0035608	sustancia	410-421	225_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
17	del	del	SP+DA	-	-	422-425	225_QUEST_clinical_caseMIR	SENT3	-	-
18	M.	m.	NCFS000	-	-	426-428	225_QUEST_clinical_caseMIR	SENT3	-	-
19	tuberculosis	tuberculosis	NCFN000	C0041296	trastorno	429-441	225_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
20	aislado	aislar	VMP00SM	-	-	442-449	225_QUEST_clinical_caseMIR	SENT3	-	-
21	en	en	SPS00	C1720294#C0332285	calificador#atributo	450-452	225_QUEST_clinical_caseMIR	SENT3	-	-
22	el	el	DA0MS0	-	-	453-455	225_QUEST_clinical_caseMIR	SENT3	-	-
23	esputo	esputo	NCMS000	C0038056	sustancia	456-462	225_QUEST_clinical_caseMIR	SENT3	-	-
24	.	.	Fp	-	-	462-463	225_QUEST_clinical_caseMIR	SENT3	-	-

1	¿	¿	Fia	-	-	464-465	225_QUEST_clinical_caseMIR	SENT4	-	-
2	Qué	qué	DT0CN0	-	-	465-468	225_QUEST_clinical_caseMIR	SENT4	-	-
3	régimen	régimen	NCMS000	C0012155	hallazgo	469-476	225_QUEST_clinical_caseMIR	SENT4	-	-
4	seleccionaría	seleccionar	VMIC3S0	-	-	477-490	225_QUEST_clinical_caseMIR	SENT4	-	-
5	en	en	SPS00	C1720294#C0332285	calificador#atributo	491-493	225_QUEST_clinical_caseMIR	SENT4	-	-
6	función	función	NCFS000	C0542341	entidad_observable#atributo	494-501	225_QUEST_clinical_caseMIR	SENT4	-	-
7	de	de	SPS00	C0332285	atributo	502-504	225_QUEST_clinical_caseMIR	SENT4	-	-
8	este	este	DD0MS0	-	-	505-509	225_QUEST_clinical_caseMIR	SENT4	-	-
9	informe	informe	NCMS000	C0684224	elemento_de_registro	510-517	225_QUEST_clinical_caseMIR	SENT4	-	-
10	?	?	Fit	-	-	517-518	225_QUEST_clinical_caseMIR	SENT4	-	-
11	.	.	Fp	-	-	518-519	225_QUEST_clinical_caseMIR	SENT4	-	-

